Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 012708
Company: MEDPOINTE PHARM HLC

Products on NDA 012708

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
DIUTENSEN-R	METHYCLOTHIAZIDE; RESERPINE	2.5MG;0.1MG	TABLET;ORAL	Discontinued	None	No	No

Approval Date(s) and History, Letters, Labels, Reviews for NDA 012708

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
09/30/1975	SUPPL-9	Labeling		Label is not available on this site.